# Nephros Inc: Form 10-Q for the period ended Jun 30, 2012

- Company: [Nephros Inc](/companies/neph.md) (CIK 1196298)
- Form: 10-Q
- Filed: 2012-08-14
- Accepted by EDGAR: Aug 14, 2012, 16:30 ET
- Period: 2012-06-30
- Accession: 0001144204-12-045753
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1196298/000114420412045753/v321080_10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1196298/000114420412045753/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-04-01 to 2012-06-30 | $302.0k | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2012-01-01 to 2012-06-30 | $835.0k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2012-04-01 to 2012-06-30 | $35.0k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2012-01-01 to 2012-06-30 | $257.0k | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-04-01 to 2012-06-30 | $267.0k | us-gaap:GrossProfit |
| Gross profit | 6 months, 2012-01-01 to 2012-06-30 | $578.0k | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2012-04-01 to 2012-06-30 | $838.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2012-01-01 to 2012-06-30 | $1.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-04-01 to 2012-06-30 | −$812.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2012-01-01 to 2012-06-30 | −$1.4m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2012-04-01 to 2012-06-30 | −$754.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2012-01-01 to 2012-06-30 | −$1.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-04-01 to 2012-06-30 | −$0.07 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2012-01-01 to 2012-06-30 | −$0.12 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2012-01-01 to 2012-06-30 | −$372.0k | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2012-01-01 to 2012-06-30 | $7.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-06-30 | $987.0k | us-gaap:Cash |
| Current assets | at 2012-06-30 | $2.2m | us-gaap:AssetsCurrent |
| Total assets | at 2012-06-30 | $4.3m | us-gaap:Assets |
| Current liabilities | at 2012-06-30 | $2.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-06-30 | $3.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2012-06-30 | $897.0k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1196298/000114420412045753/v321080_10-q.htm

Filed Aug 14, 2012.
Source: SEC EDGAR, the filing index for accession 0001144204-12-045753. Last ingested by Listed: Nov 13, 2026, 16:20 ET. No prices; not investment advice.
